(Q43037304)

English

Prediction of efficient virological response to pegylated interferon/ribavirin combination therapy by NS5A sequences of hepatitis C virus and anti-NS5A antibodies in pre-treatment sera

scientific article published in January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Prediction of efficient virological response to pegylated interferon/ribavirin combination therapy by NS5A sequences of hepatitis C virus and anti-NS5A antibodies in pre-treatment sera (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

author name string

Ahmed El-Shamy

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Mikiko Sasayama

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Motoko Nagano-Fujii

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Noriko Sasase

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Susumu Imoto

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Soo Ryang Kim

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hak Hotta

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Microbiology and Immunology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

471-482

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Predictors of response to therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Pattern of HCV antibodies with special reference to NS5A reactivity in HCV-infected patients: relation to viral genotype, cryoglobulinemia and response to interferon

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Mutations in NS5A region of hepatitis C virus genome correlate with presence of NS5A antibodies and response to interferon therapy for most common European hepatitis C virus genotypes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Prediction of treatment outcome with daily high-dose IFN alpha-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels: relationship of baseline viral levels and viral dynamics during and after therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Hepatitis C virus genotype 1a NS5A pretreatment sequence variation and viral kinetics in African American and white patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Correlation between mutations in the interferon sensitivity-determining region of NS5A protein and viral load of hepatitis C virus subtypes 1b, 1c, and 2a

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Review article: predicting response in hepatitis C virus therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV-coinfected and liver transplanted patients on peg-IFN-alpha-2b/ribavirin.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Mutations in the NS5A gene predict response to interferon therapy in Japanese patients with chronic hepatitis C and cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Analysis of sequence configurations of the ISDR, PKR-binding domain, and V3 region as predictors of response to induction interferon-alpha and ribavirin therapy in chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Prospective study on early virologic response to treatment with interferon alpha-2b plus ribavirin in patients with chronic hepatitis C genotype 1b.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Early prediction of sustained viral responder and non-responder during interferon and ribavirin combination therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Mutations in the protein kinase-binding domain of the NS5A protein in patients infected with hepatitis C virus type 1a are associated with treatment response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analyses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Hepatitis C virus NS5A protein interacts with 2',5'-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Genetic variability of hepatitis C virus in chronically infected patients with viral breakthrough during interferon-ribavirin therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03922.X

21 January 2018

Identifiers

10.1111/J.1348-0421.2007.TB03922.X

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

release_4daa7qjn6jc6vpm4nd5yy2xghq

1 reference

https://api.fatcat.wiki/v0/release/4daa7qjn6jc6vpm4nd5yy2xghq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43037304&oldid=1978286337"